Randomised pilot study comparing a coach to SMARTPhone reminders to aid the management of heart failure (HF) patients: humans or machines.

Autor: Eynan R; Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada., Petrella R; Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Forchuk C; Faculty of Health Sciences, Western University, London, Ontario, Canada., Zwarenstein M; Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada., Calvin J; Department of Medicine, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada james.calvin@lhsc.on.ca.
Jazyk: angličtina
Zdroj: BMJ open quality [BMJ Open Qual] 2024 Jul 01; Vol. 13 (3). Date of Electronic Publication: 2024 Jul 01.
DOI: 10.1136/bmjoq-2024-002753
Abstrakt: Ambulatory management of congestive heart failure (HF) continues to be a challenging clinical problem. Recent studies have focused on the role of HF clinics, nurse practitioners and disease management programmes to reduce HF readmissions. This pilot study is a pragmatic factorial study comparing a coach intervention, a SMARTPHONE REMINDER system intervention and BOTH interventions combined to Treatment as USUAL (TAU). We determined that both modalities were acceptable to patients prior to randomisation. Fifty-four patients were randomised to the four groups. The COACH group had no readmissions for HF 6 months after enrolment compared with 18% for the SMARTPHONE REMINDER Group, 8% for the BOTH intervention group and 13% for TAU. Medium-to-high medication adherence was maintained in all four groups although sodium consumption was lower at 3 months for the COACH and combined (BOTH) groups. This pilot study suggests a beneficial effect on rehospitalisation with the use of support measures including coaches and telephone reminders that needs confirmation in a larger trial.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze: MEDLINE